Abstract
Multiple Sclerosis (MS) is a neurodegenerative disease associated with cognition and balance impairments, which can lead to accidental falls. Postural control requires cognitive resources. This interaction is quantifiable by using the dual-task paradigm. The cognitive-postural interference (CPI) is commonly evaluated through an assessment of the dual-task cost (DTC). The aim of this review was to summarize literature related to process, results and effects of CPI in MS patients. The Prisma statement was used to guide this systematic review. Eligible articles had to include participants with MS for whom CPI was assessed using the DTC. A total of 14 articles meeting inclusion criteria were retained. All studies used the double stance with eyes open for the postural task component. Three types of cognitive tasks were used: Stroop Color–Word Test (SCWT), Word List Generation and Backward Counting. However, cognitive task scores in single or dual task were unavailable in 11 studies, which prevented calculating the DTC for that task. Prioritization instructions were provided in seven studies. Mutual interference was shown in three studies, postural interference in nine and postural facilitation in two. This review highlights the presence of CPI among MS patients. Postural interference usually occurred during dual task while cognitive performance during dual task was rarely reported. Postural task performance does not appear to vary based on EDSS level. We advise authors of future studies to use the SCWT in combination with postural task measure (sway area and postural sway) for DT assessment, with explicit prioritization instructions. Further, the cognitive and postural tasks should be performed in ST and DT and all results should be presented.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system affecting visual, cerebellar, sensory, and motor functions. MS is associated with executive dysfunction and postural impairments and affects quality of life in 85% of patients (). Imbalance and risk of falling are reported in early MS patients with absence of clinical disability (). Moreover, 65% of MS patients have some form of cognitive impairment ().
Postural control is defined as the body's ability to maintain adequate gravity alignment when maintaining an upright posture with voluntary and involuntary movements (). It is a complex task that requires integration of visual, vestibular, and somatosensory information by the central nervous system (). Postural control involves specific cortical areas, and attentional and executive dysfunctions are associated with motor disorders (). There is a physiological relationship between attention, cognition and balance; these functions are, respectively, treated by the frontal lobes, the thalami and the cerebellum, which are linked by a neuronal network ().
Postural and cognitive disorders were traditionally measured independently in MS patients; however, the simultaneous assessment of postural and cognitive performances demonstrated an interaction suggesting shared attentional resources (, ).
The cognitive-postural interference (CPI) is measured by performing a dual task (DT) examination, which involves conducting a postural task along with a cognitive task and comparing performance with that of single-task conditions. The dual-task cost (DTC) is used to quantify the CPI, which represents the percent difference between DT and ST performance (). Specifically, in cases where higher values indicate better performance, DTC (%) can be calculated as:
and for variables where higher values indicate worse performance as:
Further, taking consideration of the DTC of both tasks is important when assessing DTC since nine scenarios can occur: (1) No DT interference; (2) Motor Facilitation; (3) Cognitive Facilitation; (4) Mutual Facilitation; (5) Motor-related cognitive interference; (6) Cognitive-related motor interference; (7) Motor-priority trade-off; (8) Cognitive-priority trade-off; and (9) Mutual interference ().
There is interest in studying the CPI as it provides insight into real-life affectations of postural control challenges for MS patients who experience cognitive and balance disorders. However, the studies that have reported CPI in MS have used methods and inclusion criteria that differ and may present diverging results.
Two systematic reviews on the CPI were published in recent years (, ). However, these reviews included studies published before 09/01/2014 () or between 01/01/2005 and 31/10/2015 (). As CPI in persons with MS is a potentially useful clinical outcome, it is important to have the most recent information to aid further research into CPI as a clinical outcome measurement (, ).
The objective of this systematic review was to compare and contrast clinical studies that have assessed CPI in MS patients, including radiologically isolated syndrome (RIS) patients and clinically isolated syndrome (CIS) and to summarize evidence emerging from these studies.
Methods
This review is based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations, and the search strategy—including keywords and choice of databases ()—was developed in collaboration with an experienced librarian. Searches were conducted in PubMed, ScienceDirect and SPORTdiscus for potentially relevant studies without date restrictions (last updated in October 2018). The keywords applied for this search were {“Multiple Sclerosis”} AND {“Dual Task” OR “Dual Task Cost” OR Cognitive-Motor Interference”} AND {“Balance” OR “Posture”}. Previous reviews were excluded but examined to identify publications that may have been missed by our search strategy. Reference lists of eligible studies were also reviewed to ensure that all potentially eligible studies were retrieved. Eligible studies were peer-reviewed and original studies, published in either English or French, whose MS participants were performing postural (i.e., double stance, eyes open) and cognitive tasks at the same time. All types of quantitative study designs were eligible for this review.
The exclusion criteria were: (1) studies concerning walking; (2) studies concerning effectiveness of rehabilitation process; and (3) studies concerning effectiveness of medications, unless the pre-treatment data were available.
Once duplicates were removed, titles and abstracts were assessed independently by two reviewers (LCW and MM). The full texts of articles considered potentially eligible were then assessed. Any disagreement between the two reviewers led to a discussion and group-based decision about study inclusion. Results extraction was also conducted by two independent reviewers (LCW and MM). Quality assessment was performed with two tools, the National Service Framework Typology of Evidence—Quality Assessment (NSFTE—QA) () and the Quality Assessment of Diagnostic Accuracy Studies 2 tool (QUADAS-2) (). For the QUADAS-2 tool, we applied it in the same manner that was described by Learmonth et al. (), for the assessment of the judgement of bias for patient selection, index test and flow of the participants. We modified our judgment of bias for the reference standard element to whether or not there were baseline measures of the ST for each of the cognitive and motor tasks for each study. Study type, methodological information, inclusion criteria, number of MS and control participants, Expanded Disability Status Scale (EDSS) score, type of cognitive and postural tasks, and performance scores in single (cognitive and postural) and in dual task were collected. The DTC for the MS participants was calculated for each study. When a large amount of posture and cognitive data were available in an article, the sway area and the Stroop color and word test (SCWT) () were used in the DTC calculation, as they were the most frequently used tests, which facilitated data comparison. It is important to note that the DTC values were calculated using the group average performance of the single and dual task (cognitive and postural). The DTC was then represented on a graph to classify CPI patterns. A balance variable was presented on the X-axis, where a positive result was indicative of improved balance (reduced sway area) during the DT and a negative result would show impaired balance (increased sway area) compared to the ST. Similarly, a negative to positive continuum was used to represent the cognitive variable on the Y-axis ().
Results
A total of 42 distinct references were found. Of these, 23 were excluded after reading the titles and abstracts, and seven more were excluded once they were read in full. Two additional articles were then added to the list following verification of authors' libraries, for a total of 14 articles included in this literature review (Figure 1).
Figure 1
The 14 manuscripts were published between 2010 and 2018 (Table 1). Most of these studies (nine) were cross-sectional and seven had a control group of healthy subjects. One publication had a patient group consisting of subjects with CIS (
Table 1
| ID | Study | Level of evidence /study design/participants/ inclusion criteria | EDSS | Cognitive task/ ST performance/ DT performance | Posture task/ ST performance/ DT performance | Cognitive DTC | Postural DTC (double stance with eye open) | Prioritization instruction/ DTC calculus | Quality | |
|---|---|---|---|---|---|---|---|---|---|---|
| NFSTE | QUADAS-2 (high risk domains only) | |||||||||
| A | Boes et al. ( | Level II Cross-sectional N = 45 adults with MS diagnosis, EDSS 6.5 or less and Relapse-free for 30 days Mild disability group, n = 19 (46.4 (13.1), F: 17, M: 2) Moderate disability group, n = 26 (58.2 (7.5), F: 24, M: 2) | Median Total 4.0 [2.0–6.5] Mild 3.0 [2.0–3.5] Moderate 6.0 [4.0–6.5] | Verbal fluency (semantic and phonemic) (# words/30 s): ST and DT performance not described | MS Total: Sway area (mm2): ST: 200.6 DT: 277.3 Median Velocity-AP (mm): ST: 6.8 DT: 8.6 Median velocity-ML (mm): ST: 8.5 DT: 11.9 Root mean square displacement-ML (mm): ST: 5.7 DT: 6.8 | Not described | MS Total: Sway area: −38.2% Median velocity-AP: −26.5% Median velocity-ML: −40.0% Root mean square displacement-ML: −19.3% | Not described DTC were calculated with the average among the MS group (mild + moderate group) | High | Reference standard |
| B | Castelli et al. ( | Level III Cross-sectional N = 75 adults (37.8 (9.8), F: 53, M: 22) with MS diagnosis, EDSS 3.0 or less, Stand upright for 180 s, Relapse-free for 3 months, No severe vision impairment, No severe cognitive impairment, No depression | Median 2.0 [0–3.0] | SCWT (# word's true color/30 s): ST and DT performance not described | Postural sway (mm): ST: 220.0 DT: 332.0 | Not described | Postural sway: −50.9% | Cognition DTC was calculated with the average among the MS group | High | Reference standard |
| C | Castelli et al. ( | Level III Prospective single-group intervention N = 22 adults (49.7 (8.3), F: 13, M: 9) with MS diagnosis, Numerical rating Scale ≥ 4, Moderate to severe spasticity, Lack to response to antispastic drugs | Median 5.0 [2.5–6.5] | SCWT (# word's ink color/30 s) ST: 22.6 DT: 20.7 | Postural Sway (mm): ST: 305.0 DT: 456.0 | SCWT: −8.4% | Postural Sway: −49.5% | Cognition DTC were calculated with the average among the MS group | High | None |
| D | Dattola et al. ( | Level II Cross-sectional N = 20 RIS group, n = 10 adults (33.8 [24–42], F: 7, M: 3) with Okuda's criteria MRI for RIS Control group, n = 10 healthy adults (35.0 [29–41], F: 5, M: 5) with no history of known psychiatric or neurological disorders | Non available | Verbal fluency (semantic and phonemic) (# words/50 s): ST and DT performance not described | Sway area (mm2): RIS-ST: 86.6 Control-ST: 87.2 Semantic Fluency RIS-DT: 105.4 Control-DT: 89.9 Phonemic Fluency RIS-DT: 107.2 Control-DT: 90.6 Ellipse eccentricity (%): RIS-ST: 51.6 Control-ST: 52.2 Semantic Fluency RIS-DT: 55.3 Control-DT: 54.1 Phonemic Fluency RIS-DT: 58.3 Control-DT: 54.1 Sway path length (mm): RIS-ST: 111.5 Control-ST: 110.8 Semantic Fluency RIS-DT: 145.0 Control-DT: 120.2 Phonemic Fluency RIS-DT: 150.0 Control-DT: 124.1 Median velocity-AP (mm/s): RIS-ST: 1.3 Control-ST: 1.3 Semantic Fluency RIS-DT: 2.7 Control-DT: 1.5 Phonemic Fluency RIS-DT: 2.9 Control-DT: 1.5 Median velocity-ML (mm/s): RIS-ST: 1.4 Control-ST: 1.4 Semantic Fluency RIS-DT: 2.8 Control-DT: 1.6 Phonemic Fluency RIS-DT: 2.9 Control-DT: 1.6 | Not described | Sway area: Semantic Fluency RIS: −21.7% Control: −3.1% Phonemic Fluency RIS: −23.8% Control: −3.9% Ellipse eccentricity: Semantic Fluency RIS: −7.2% Control: −3.6% Phonemic Fluency RIS: −13.0% Control: −3.6% Sway path length: Semantic Fluency RIS: −30.0% Control: −8.5% Phonemic Fluency RIS: −34.5% Control: −12.0% Median velocity-AP: Semantic Fluency RIS: −107.7% Control: −15.4% Phonemic Fluency RIS: −123.1% Control: −15.4% Median velocity-ML: Semantic Fluency RIS: −100.0% Control: −14.3% Phonemic Fluency RIS: −107.1% Control: −14.3% | Not described DTC were calculated with the average among the two groups | High | Patient selection, Index test, Reference standard |
| E | Etemadi et al. ( | Level II Prospective cohort. N = 60 adults with RRMS diagnosis, Age 20–45 yo, Stand upright for 60 s, Relapse-free for 1 month, Walk 100 m, No severe vision impairment, No severe cognitive impairment Group ≤ 1 fall, n = 34 adults (39.2 (5.1), F: 22, M: 12) Group ≥ 2 falls, n = 26 adults (41.7 (6.3), F: 16, M: 10) | Mean Group ≤ 1 fall: 4.0 (0.5) Group ≥ 2 falls: 5.0 (2.0) | Silent backward counting in multiples of seven (correct response rate): MS-ST: 36.83 ST and DT performance not described | Sway area (mm2): MS-ST: 295.5 DT performance not described | MS: −3.4% | MS: −12.4% | Not described DTC were indicated in the article | High | None |
| F | Kalron et al. ( | Level II Observational Case Control N = 80 CIS group, n = 52 adults (35.2 (1.3), F: 36, M: 16) with CIS diagnosis, Age 20–45 yo, 90 days after onset of symptoms, 1 month free of steroid therapy Control group, n = 28 healthy adults (32.8 (1.2), F: 20, M: 8) | Mean 1.7 (0.2) [0–5.0] | SCWT (# word's true color/30 s): ST and DT performance not described | SD of the ML movement: CIS-ST: 27.0 Control-ST: 13.9 CIS-DT: 37.0 Control-DT: 20.9 SD of the AP movement: CIS-ST: 56.0 Control-ST: 41.3 CIS-DT: 57.2 Control-DT: 40.1 Plane SD (mm): CIS-ST: 63.8 Control-ST: 44.0 CIS-DT: 69.2 Control-DT: 46.2 Sway Rate (mm/s): CIS-ST: 7.9 Control-ST: 4.7 CIS-DT: 11.3 Control-DT: 6.3 | Not described | Standard deviation of the ML movement: CIS: −37.0% Control: −50.4% Standard deviation of the AP movement: CIS: −2.1% Control: +2.9% Plane standard deviation: CIS: −8.5% Control: −5.0% Sway Rate: CIS: −43.0% Control: −34.0% | Both DTC were calculated with the average among the two groups | High | Patient selection, Index test, Reference standard |
| G | Negahban et al. ( | Level II Cross-sectional N = 46 MS group, n = 23 adults (32.7 (7.9), F: 15, M: 8) with RRMS diagnosis, EDSS 5.0 or less, Stand upright for 30 s, Walk for 100 m, No severe vision impairment, No severe cognitive impairment Control group, n = 23 healthy adults (31.4 (7.9), F: 15, M: 8) matched with the patients according to gender, age, height, body mass index, years of education, and MMSE | Mean 2.5 (1.1) | Silent backward counting in multiples of three (# of subtracting item): ST and DT performance not described | Mean total velocity (cm/s): MS-ST: 1.2 Control-ST: 1.1 MS-DT: 1.2 Control-DT: 0.9 Sway area (cm2): MS-ST: 3.4 Control-ST: 2.2 MS-DT: 2.6 Control-DT: 1.0 SD velocity-AP (cm/s): MS-ST: 1.4 Control-ST: 1.3 MS-DT: 1.4 Control-DT: 0.9 SD velocity-ML (cm/s): MS-ST: 1.7 Control-ST: 1.5 MS-DT: 1.5 Control-DT: 1.3 | Not described | Mean total velocity (cm/s): MS: 0% Control: +18.2% Sway area (cm2): MS: +23.6% Control: +54.6% SD velocity-AP (cm/s): MS: 0% Control: +30.8% SD velocity-ML (cm/s): MS: +11.8% Control: +13.3% | Both DTC were calculated with the average among the two groups | High | Reference standard |
| H | Negahban et al. ( | Level III Prospective single-group intervention N = 38 adults (36.0 (8.0), F: 30, M: 8) with RRMS diagnosis, EDSS 2.0 to 5.5, Able to stand without any support, Walk for 100 m, No severe cognitive impairment | Mean 2.8 (1.09) | Silent backward counting in multiples of seven (# of subtracting item): ST and DT performance not described | Mean velocity (cm/s): ST: 1.7 DT: 1.5 SD velocity-AP (cm/s): ST: 0.8 DT: 0.7 SD velocity-ML (cm/s): ST: 1.0 DT: 0.9 SD amplitude-AP (cm): ST: 0.5 DT: 0.5 SD amplitude-ML (cm): ST: 0.6 DT: 0.6 Area (cm2): ST: 11.2 DT: 9.9 | Not described | Mean velocity: +11.8% SD Velocity-AP: +12.5% SD velocity-ML: +10.0% SD amplitude-AP: 0.0% SD amplitude-ML: 0.0% Area: +11.6% | Cognition DTC were calculated with the average among the MS group | High | Reference standard |
| I | Porosinska et al. ( | Level II Cross-sectional N = 62 MS group, n = 32 adults (33.5 (10.6), F: 22, M: 10) with MS diagnosis, Stand upright for 60 s, No severe pain, nystagmus and vertigo, No severe cognitive impairment Control group, n = healthy adults (28.0 (9.9), F: 20, M: 10) matched with the patients according to gender and age | Mean 2.4 (1.1) [1.0–4.5] | Backward counting from 100 to 0: ST and DT performance not described | Sway length-ML (scale not specified): MS-ST: 3.0 Control-ST: 1.9 MS-DT: 3.5 Control-DT: 1.7 Sway length-AP (scale not specified): MS-ST: 3.8 Control-ST: 2.9 MS-DT: 4.0 Control-DT: 3.3 Sway velocity (scale not specified): MS-ST: 13.7 Control-ST: 9.1 MS-DT: 17.7 Control-DT: 10.2 | Not described | Sway length-ML: MS: −16.7% Control: +10.5% Sway length-AP: MS: −5.3% Control: −13.8% Sway velocity: MS: −29.2% Control: −12.1% | Not described DTC were calculated with the average among the two groups | High | Reference standard |
| J | Prosperini et al. ( | Level II Cross-sectional N = 138 MS group, n = 92 adults (39.2 (10.1), F: 60, M: 32) with RR or SP diagnosis, Age 18–55 yo, Stand upright for 180 s, Relapse-free for 3 months, No severe vision impairment, No severe cognitive impairment, No severe depression Control group, n = 46 healthy adults (39.3 (9.8), F: 30, M: 16) matched with the patients according to gender, age and education | Median 2.5 [1.0–6.0] | SCWT (# word's true color/30 s): ST and DT performance not described | COP path (mm): MS-ST: 298 Control-ST: 198 MS-DT: 405 Control-DT: 231 | Not described | COP path: MS: −36.0% Control: −16.7% | Cognition DTC were calculated with the average among the two groups | High | Reference standard |
| K | Prosperini et al. ( | Level II Cross-sectional N = 78 MS group, n = 52 adults (48.6 (8.8), F: 30, M: 22) with MS diagnosis, Age 18–55 yo, Stand upright for 180 s, Relapse-free for 3 months, No severe cognitive impairment, No severe depression, No major medication change in the last month Control group, n = 26 healthy adults (46.4 (8.1), F: 15, M: 11) matched with the patients according to gender and age | Median 3.0 [1.0–5.5] | SDMT (# correct symbols/30 s): MS-ST: 13.8 Control-ST: 18.8 MS-DT: 13.6 Control-DT: 17.7 Verbal fluency-semantic (# words/30 s): MS-ST: 18.1 Control-ST: 22.0 MS-DT: 16.7 Control-DT: 21.4 SCWT (# word's ink color/30 s): MS-ST: 19.5 Control-ST: 27.9 MS-DT: 18.2 Control-DT: 26.3 | Postural Sway (mm): MS-ST: 300 Control-ST: 209 Symbol digit modalities test: MS-DT: 346 Control-DT: 246 Verbal fluency-semantic: MS-DT: 393 Control-DT: 262 SCWT: MS-DT: 445 Control-DT: 285 | SDMT: MS: −1.5 % Control: −5.9% Verbal fluency-semantic: MS: −7.7% Control: −2.7 % SCWT: MS: −6.7% Control: −5.7% | Postural sway symbol digit modalities test: MS: −15.3% Control: −17.7% Verbal fluency-semantic: MS: −31.0% Control: −25.4% SCWT: MS: −48.3% Control: −36.4% | Cognition DTC were calculated with the average among the two groups | High | None |
| L | Ruggieri et al. ( | Level II Cross-sectional N = 144 MS group, n = 96 adults (41.8 (10.6), F: 64, M: 32) with MS diagnosis, EDSS 0–6.5, Age 18–55 yo, Stand upright for 180 s, Relapse-free for 3 months, No severe vision impairment Control group, n = 48 healthy adults (40.7 (8.6), F: 32, M: 16) matched with the patients according to gender and age | Median 3.0 [1.0–6.0] | SCWT (# word's ink color /30 s): MS-ST: 20.1 Control-ST: 27.8 DT performance not described | Postural sway (mm): MS-ST: 308 Control-ST: 198 MS-DT: 427 Control-DT: 245 | Not described | Postural sway MS: −38.6% Control: −23.7% | Posture DTC were calculated with the average among the two groups | High | Reference standard |
| M | Wajda et al. ( | Level III Cross-sectional N = 62 adults (60.9 [42–76], F: 46, M: 16) with MS diagnosis, Age over 40 yo Relapse-free for 1 month Fall in the previous year Stand upright for 30 s | Median 6.0 [0–7.0] | Verbal fluency -semantic and phonemic (# words/30 s): ST performance not described DT: 12.3 | Sway area (mm2): ST: 1471.6 DT: 2006.2 | Not described | Sway area: MS: −93.40% | Not described DTC was indicated in the article | High | Index test, Reference standard |
| N | Wajda et al. ( | Level III Prospective single group N = 20 adults (61.1 (6.0), F: 18, M: 2) with MS diagnosis, Age 50–75 yo, Relapse-free for 1 month, Fall in the previous year, Walk without assistive device for 6 minutes | Median 5.0 (IQR = 2.5) | Verbal fluency -semantic and phonemic (# words/30 s): ST and DT performance not described | Mean velocity-AP (mm/s): ST: 15.8 DT: 19.3 Mean velocity-ML (mm/s): ST: 9.1 DT: 11.3 Sway area (mm2): ST: 1836 DT: 2158 95% confidence ellipse (mm2): ST: 938 DT: 877 | Not described | Mean velocity-AP: −22.2% Mean velocity-ML: −24.2% Sway area: −17.5% 95% Confidence ellipse: +6.5% | Not described DTC were calculated with the average among the MS group | High | Reference standard |
Summary of the characteristics of the studies included in the review.
Values are represented in mean (± standard deviation) or median [range]. DTC is expressed in percentage. COP, Center of Pressure; DTC, Double Task Cost; MS, Multiple Sclerosis; RIS, Radiologically Isolated Syndrome; CIS, Clinically Isolated Syndrome; RR, Relapsing-Remitting; SP, Secondary Progressive; EDSS, Expanded Disability Status Scale; s, seconds; yo, years old; m, meters; McDonald, McDonald criteria (
The DTC scores for this study were provided directly in the article and they are the values that appear in this table. All of the other values were calculated based on the group means available in the articles. Please see the limitations section for more information.
The median EDSS score of MS patients included ranged from 2.0 to 6.0, while the average EDSS score ranged from 1.7 to 2.8. The cognitive tasks chosen were tasks that we could qualify as executive function tests. In six studies it was the SCWT, which measures mental flexibility and inhibition capacity (
For the postural task, participants were evaluated on a force platform where the center of pressure was generated by trials in a double stance with eyes open. Many centers of pressure metrics (e.g., postural sway, sway velocity, and sway area) were generated, but several articles did not have the same center of pressure metrics. Regarding the number of trials, eight studies did only one trial for each postural condition (
When it was not directly available in the article, we calculated the cognitive and postural DTC from the available data. The graphical representation of the DTC results from all of the eligible studies is presented in Figure 2. Only three articles had the baseline scores of the cognitive task (during the ST). In these studies, the cognitive/postural DTC showed mutual interference (
Figure 2

Graphical representation of the DTC (MS subjects) for the included studies of the review. Prioritization instructions: ♢, No instructions, □, Posture, ▵, Cognition, ◦, Both tasks. The DTC from de study of Datolla et al. (
Prioritization instructions were explicitly stated in eight publications, for either the postural task or the cognitive, or both. Five studies (
Concerning the group differences for the DTC, there were five studies that reported postural interference during the DT condition for both the control groups and the MS groups, with the MS groups showing the largest interference (
Discussion
In this study, we systematically reviewed methods and results of 14 studies assessing CPI in MS patients. Despite considerable variation in research protocols, most studies documented that DT is associated with a motor related-cognitive interference or motor interference. This signifies that the postural task is affected when the MS patient simultaneously performs a cognitive task. This creates increased falling risks for MS patients in many common situations during activities of daily living, such as standing and talking on the telephone or withdrawing money from an automated banking machine (
It would seem that during the DT, the neurological processes associated with postural control and attention share the same neural network in MS patients, which can lead to a deterioration of the postural performance during the DT or vice versa (
Several theories have been posited to explain the CPI. First, the attentional capacity theory suggests that an individual has a limit to his or her ability to pay attention. During the DT, the capacity is exceeded and one or both tasks' performance will decline (
This last theory could explain the results of the two studies where there was a postural improvement during the DT (
Although the postural task used was similar across studies, the cognitive tasks varied. For example, the SCWT evaluates the executive functions that are most often affected in MS, such as processing speed, long-term memory and attention (
Only one study compared various cognitive tasks within their sample population. Prosperini et al. (
Some studies were interested in MS patients with little or no disability, and those that did investigate found that there was a CPI in the early stage of the disease, such as RIS and CIS patients (
The EDSS score seemed to be an important factor to have homogeneous groups, as it was a frequent inclusion criterion. However, one with severely disabled patients did not show more severe interference (
Only three studies (
Concerning group differences, seven studies included a control group thus permitting the comparison between controls and MS participants. For all seven studies the control groups always performed better than the MS participants, thus indicating that the performance of a DT negatively affects the MS groups more than the control groups. However, there was one exception for one specific cognitive task (i.e., SDMT) in the study by Prosperini et al. (
This systematic review is not without limitations, the primary limitation is in the manner that our DTC scores were obtained. The DTC scores presented in Table 1 were either presented directly in the text of the articles (
In conclusion, this review highlights the presence of a CPI, whereby impairments in MS patients are associated with postural interference in situations of DT. The level of postural interference was not related to the degree of incapacity as determined by EDSS score. These results suggest that situations when MS patients have to deal with postural and cognitive tasks simultaneously expose them to increased balance impairment, an important precursor of risk of falls. From an assessment perspective, recommendations emanating from this review include that the SCWT appears as the most appropriate cognitive task to use in combination with postural task measure (sway area and postural sway) in the context of DT assessment. Also, DT assessment requires delivery of explicit prioritization instructions to avoid conscious prioritization of one task over another. Further, the cognitive and postural tasks must be performed in ST and DT, and all the results must be presented to provide a clear understanding of CPI affectations.
Statements
Data availability statement
All datasets generated for this study are included in the manuscript/supplementary files.
Author contributions
MM authored the original draft of this systematic review. LC and GH contributed to the modification of the manuscript for submission. MB and AM provided critical feedback and helped shape the final version of the manuscript. MM and GH contributed equally to the conception of the idea upon which is based this manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1.
LaroccaNG. Impact of walking impairment in multiple sclerosis : perspectives of patients and care partners. Patient. (2011) 4:189–201. 10.2165/11591150-000000000-00000
2.
MartinCLPhillipsBAKilpatrickTJButzkuevenHTubridyNMcDonaldEet al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler J. (2006) 12:620–8. 10.1177/1352458506070658
3.
ChiaravallotiNDDeLucaJ. Cognitive impairment in multiple sclerosis. Lancet Neurol. (2008) 7:1139–51. 10.1016/S1474-4422(08)70259-X
4.
PollockASDurwardBRRowePJPaulJP. What is balance?Clin Rehabil. (2000) 14:402–6. 10.1191/0269215500cr342oa
5.
MarsdenCDMertonPAMortonHB. Human postural responses. Brain. (1981) 104:513–34. 10.1093/brain/104.3.513
6.
Yogev-SeligmannGHausdorffJMGiladiN. The role of executive function and attention in gait. Mov Disord. (2008) 23:329–42. 10.1002/mds.21720
7.
RuggieriSFanelliFCastelliLPetsasNDe GiglioLProsperiniL. Lesion symptom map of cognitive–postural interference in multiple sclerosis. Mult Scler J. (2018) 24:653–62. 10.1177/1352458517701313
8.
WoollacottMShumway-CookA. Attention and the control of posture and gait tte review of an emerging area of research. Gait Posture. (2002) 16:1–14. 10.1016/S0966-6362(01)00156-4
9.
WajdaDASosnoffJJ. Cognitive-motor interference in multiple sclerosis: a systematic review of evidence, correlates, and consequences. Bio Med Res Int. (2015) 2015:720856. 10.1155/2015/720856
10.
PlummerPEskesG. Measuring treatment effects on dual-task performance: a framework for research and clinical practice. Front Human Neurosci. (2015) 9:225. 10.3389/fnhum.2015.00225
11.
PlummerPEskesGWallaceSGiuffridaCFraasMCampbellGet al. Cognitive-motor interference during functional mobility after stroke: state of the science and implications for future research. Arch Phys Med Rehabil. (2013) 94:2565–74 e6. 10.1016/j.apmr.2013.08.002
12.
LearmonthYCEnsariIMotlRW. Cognitive motor interference in multiple sclerosis: insights from a systematic quantitative review. Arch Phys Med Rehabil. (2017) 98:1229–40. 10.1016/j.apmr.2016.07.018
13.
MoherDLiberatiATetzlaffJAltmanDGGroupTP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. (2009) 6:e1000097. 10.1371/journal.pmed.1000097
14.
Turner-StokesLHardingRSergeantJLuptonCMcPhersonK. Generating the evidence base for the National Service Framework for long term conditions : a new research typology. Clin Med. (2006) 6:91–7. 10.7861/clinmedicine.6-1-91
15.
WhitingPF. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Internal Med. (2011) 155:529. 10.7326/0003-4819-155-8-201110180-00009
16.
StroopJR. Studies of interference in serial verbal reactions. J Exp Psychol. (1935) 18:643–62. 10.1037/h0054651
17.
BoesMKSosnoffJJ.SocieMJSandroffBMPulaJHMotlRW.Postural control in multiple sclerosis: effects of disability status and dual task. J Neurol Sci. (2012) 315:44–8. 10.1016/j.jns.2011.12.006
18.
CastelliLDe LucaFMarchettiMRSellittoGFanelliFProsperiniL. The dual task-cost of standing balance affects quality of life in mildly disabled MS people. Neurol Sci. (2016) 37:673–9. 10.1007/s10072-015-2456-y
19.
CastelliLProsperiniLPozzilliC. Balance worsening associated with nabiximols in multiple sclerosis. Mult Scler J. (2019) 25:113–7. 10.1177/1352458518765649
20.
DattolaVLogiudiceALBonannoLFamàFMilardiDChillemiGet al. Does the radiologically isolated syndrome exist? A dual-task cost pilot study. Neurol Sci. (2017) 38:2007–13. 10.1007/s10072-017-3094-3
21.
EtemadiY. Dual task cost of cognition is related to fall risk in patients with multiple sclerosis: a prospective study. Clin Rehabil. (2017) 31:278–84. 10.1177/0269215516637201
22.
KalronADvirZAchironA. Effect of a cognitive task on postural control in patients with a clinically isolated syndrome suggestive of multiple sclerosis. Eur J Phys Rehabil Med. (2011) 47:579–86.
23.
NegahbanHMofatehRArastooAAMazaheriMYazdiMJSSalavatiMet al. The effects of cognitive loading on balance control in patients with multiple sclerosis. Gait Posture. (2011) 34:479–84. 10.1016/j.gaitpost.2011.06.023
24.
NegahbanHMonjeziSMehravarMMostafaeeNShoeibiA. Responsiveness of postural performance measures following balance rehabilitation in multiple sclerosis patients. J Bodywork Mov Ther. (2018) 22:502–10. 10.1016/j.jbmt.2017.06.008
25.
PorosinskaAPierzchałaKMentelMKarpeJ. Evaluation of postural balance control in patients with multiple sclerosis – effect of different sensory conditions and arithmetic task execution. A pilot study. Neurol Neurochir Pol. (2010) 44:35–42. 10.1016/S0028-3843(14)60405-9
26.
ProsperiniLCastelliLSellittoGDe LucaFDe GiglioLGurreriFet al. Investigating the phenomenon of “cognitive-motor interference” in multiple sclerosis by means of dual-task posturography. Gait Posture. (2015) 41:780–5. 10.1016/j.gaitpost.2015.02.002
27.
ProsperiniLCastelliLDe LucaFFabianoFFerranteIDe GiglioL. Task-dependent deterioration of balance underpinning cognitive-postural interference in MS. Neurology. (2016) 87:1085–92. 10.1212/WNL.0000000000003090
28.
WajdaDAMotlRWSosnoffJJ. Correlates of dual task cost of standing balance in individuals with multiple sclerosis. Gait Posture. (2014) 40:352–6. 10.1016/j.gaitpost.2014.04.209
29.
WajdaDAMotlRWSosnoffJJ. Three-month test-retest reliability of center of pressure motion during standing balance in individuals with multiple sclerosis. Int J MS Care. (2016) 18:59–62. 10.7224/1537-2073.2015-014
30.
McDonaldWICompstonAEdanGGoodkinDHartungH-PLublinFDet al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. (2001) 50:121–7. 10.1002/ana.1032
31.
PolmanCHReingoldSCBanwellBClanetMCohenJAFilippiMet al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. (2011) 69:292–302. 10.1002/ana.22366
32.
BarbarottoRLaiaconaMFrosioRVecchioMFarinatoACapitaniE. A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci. (1998) 19:161–70. 10.1007/BF00831566
33.
StraussEShermanEMSSpreenO. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press.
34.
RaghubarKPBarnesMAHechtSA. Working memory and mathematics: a review of developmental, individual difference, and cognitive approaches. Learn Individual Differ. (2010) 20:110–22. 10.1016/j.lindif.2009.10.005
35.
PashlerH. Graded capacity-sharing in dual-task interference?J Exp Psychol Human Percept Perform. (1994) 20:330–42. 10.1037//0096-1523.20.2.330
36.
PatelPLamarMBhattT. Effect of type of cognitive task and walking speed on cognitive-motor interference during dual-task walking. Neuroscience. (2014) 260:140–8. 10.1016/j.neuroscience.2013.12.016
37.
ComberLSosnoffJJGalvinRCooteS. Postural control deficits in people with Multiple Sclerosis: a systematic review and meta-analysis. Gait Posture. (2018) 61:445–52. 10.1016/j.gaitpost.2018.02.018
38.
RuggieriRMPalermoRVitelloGGennusoMSettipaniNPiccoliF. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5. Acta Neurol Scand. (2003) 108:323–6. 10.1034/j.1600-0404.2003.00157.x
39.
PattiFAmatoMPTrojanoMBastianelloSTolaMRGorettiBet al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler. (2009) 15:779–88. 10.1177/1352458509105544
40.
VanderhasseltM-ADe RaedtRBaekenC. Dorsolateral prefrontal cortex and Stroop performance: tackling the lateralization. Psychon Bull Rev. (2009) 16:609–12. 10.3758/PBR.16.3.609
41.
RicherNLyKFortierNLajoieY. Absence of ankle stiffening while standing in focus and cognitive task conditions in older adults. J Motor Behav. (2019) 1–8. 10.1080/00222895.2019.1599808
Summary
Keywords
dual-task, multiple sclerosis, cognition, postural control, balance, cognitive-postural interference
Citation
Chamard Witkowski L, Mallet M, Bélanger M, Marrero A and Handrigan G (2019) Cognitive-Postural Interference in Multiple Sclerosis. Front. Neurol. 10:913. doi: 10.3389/fneur.2019.00913
Received
04 June 2019
Accepted
06 August 2019
Published
23 August 2019
Volume
10 - 2019
Edited by
Brian M. Sandroff, University of Alabama at Birmingham, United States
Reviewed by
Renee Veldkamp, University of Hasselt, Belgium; Ricardo Constantino Ginestal, Hospital Clínico San Carlos, Spain
Updates

Check for updates
Copyright
© 2019 Chamard Witkowski, Mallet, Bélanger, Marrero and Handrigan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ludivine Chamard Witkowski ludivine_chamard@hotmail.com
This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Neurology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.